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DObjectives: Pulmonary artery stenosis is a potential complication after Norwood palliation for hypoplastic left
heart syndrome. It is unclear whether the shunt type or position in the Norwood procedure is associated with the
risk of the development of pulmonary artery stenosis. We examined the risk of pulmonary artery stenosis and the
need for pulmonary artery intervention in children undergoing the Norwood procedure with either the right ven-
tricle to pulmonary artery conduit or modified Blalock-Taussig shunt.
Methods: A retrospective review was performed of all patients who underwent the Norwood procedure from
January 1, 2003, to September 1, 2011. The data from 100 patients were reviewed, including catheterization
and echocardiographic data, right ventricle to pulmonary artery conduit (n ¼ 67, right shunt position in 17
and left in 50), and right ventricle to pulmonary artery (n ¼ 33). The primary outcome measure was the need
for operative or catheter-based pulmonary artery intervention.
Results: No patients in the right ventricle to pulmonary artery group required catheterization-based pulmonary
artery interventions. Surgical pulmonary arterioplasty was performed frequently and equally in both the right
ventricle to pulmonary artery and right ventricle to pulmonary artery groups at the bidirectional Glenn proce-
dure. Catheter-based pulmonary arterioplasty was performedmore frequently in the right ventricle to pulmonary
artery conduit group, especially when the conduit was positioned to the right side of the neoaorta. These patients
had a 12.73 increased odds of a pulmonary artery intervention compared with the left to right ventricle to pul-
monary artery conduit (P ¼ .04).
Conclusions: Consistent with a previous multicenter randomized trial, patients who received a right ventricle to
pulmonary artery conduit versus a right ventricle to pulmonary artery have a greater risk of requiring pulmonary
artery interventions. Patients with right ventricle to pulmonary artery conduit placement to the right underwent
a greater number of pulmonary artery interventions but demonstrated overall improved growth of the branch
pulmonary arteries compared with the patients receiving a left-sided right ventricle to pulmonary artery conduit.
(J Thorac Cardiovasc Surg 2013;145:1485-92)Earn CME credits at
http://cme.ctsnetjournals.org
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shunt (mBTS) or a right ventricle to pulmonary artery
(RV-PA) conduit.
Successful palliation is dependent on the optimal growth
and development of the pulmonary vasculature. The shunt
type and position might be associated with differences in
pulmonary artery (PA) growth and the potential need for
PA intervention.1-5 Controversy exists over which shunt
type and the relative position (right or left of the
neoaorta) is associated with the development of important
PA stenosis and the best PA growth.1,2,5-10
The purposes of the present study were (1) to determine
whether the shunt type (mBTS vs RV-PA conduit) was asso-
ciated with the need for catheter-based PA intervention and
(2) to determine whether the position of the RV-PA conduit
to the left or right side of the neoaorta was associated with
the need for catheter-based PA intervention.
METHODS
All patients who underwent the NP from January 2003 to September
2011 were included in the present study. None of the patients underwent
a hybrid procedure. The patient cohort was divided according to the shunt
type used: the RV-PA conduit in 67 and the mBTS in 33. The RV-PAdiovascular Surgery c Volume 145, Number 6 1485
Abbreviations and Acronyms
BDG ¼ bidirectional Glenn
CI ¼ confidence interval
HLHS ¼ hypoplastic left heart syndrome
mBTS ¼ modified Blalock-Taussig shunt
NP ¼ Norwood procedure
PA ¼ pulmonary artery
RV-PA ¼ right ventricle to pulmonary artery
Qp/Qs ¼ pulmonary/systemic blood flow
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Dconduit cohort was further stratified into 2 groups according to the conduit
position in relationship to the neoaorta: left in 50 and right in 17. The
primary outcomes included the need for operative or catheter-based PA
intervention, operative and interstage mortality, and the need for cardiac
transplantation before the Fontan procedure. Operative mortality was de-
fined as death occurring in the hospital or within 30 days of surgery11 and
was divided into 2 eras, early (2003-2008) and late (2009-2011). The Uni-
versity of Colorado institutional review board approved the present study.
Echocardiograms were evaluated before the NP and BDG procedure. If a
patient required PA intervention, the echocardiogram preceding any
intervention was used (all follow-up echocardiograms are referred to as pre-
BDG echocardiograms). Right ventricular function, tricuspid valve function,
andPAmeasurementswere evaluatedby echocardiography before theNPand
BDG procedure. A single cardiac sonographer whowas unaware of the oper-
ative or catheter-based PA interventions reviewed all echocardiograms.
Tricuspid valve regurgitationwas graded using the colorDoppler patterns
in accordance with the American Society of Echocardiography and graded
on a scale of 0 to 6 (0, none; 1, trivial; 2, mild; 3, mild to moderate; 4, mod-
erate; 5, moderate to severe; and 6, severe).12 Right ventricular function was
recorded as normal, mildly reduced, moderately reduced, or severely re-
duced. The branch PA dimensions were measured from the parasternal or
suprasternal short-axis views at the hilum of the vessel (before the first
branching point). If the images were suboptimal for measurement, the data
were excluded. PA growth was evaluated by echocardiography. A change
in PA sizewas determined for noninvasive evaluation of PAgrowthafter con-
trolling for weight and the number of days between the echocardiograms.
The angiograms were reviewed, and the PA dimensions were measured
off-line using an empty catheter of known size for calibration. The dimen-
sion of the descending thoracic aorta was determined at the level of the di-
aphragm using the same calibration technique. The right and left PA size,
McGoon index, and Nakata index were determined from the pre-BDG
catheterization procedure.13,14 The total number of catheter procedures
and interventions were determined for each stage. The angiographic
measurements were made before an intervention on the PAs.
Statistical Analysis
The data were collected using Research Electronic Data Capture.15 The
data were analyzed using SPSS (SPSS, version 12, for Windows, release
12.0.7; SPSS, Chicago, Ill). The categorical variables were compared using
the chi-square test or Fisher’s exact test. Continuous variables are reported
as the mean standard deviation and were compared using I tests. Logistic
regression analysis was used to determine the association between the
shunt position and the need for PA intervention.RESULTS
Comparison of mBTS and RV-PA Conduit
The patient demographics and operative characteristics
for the comparison of shunt type are listed in Table 1.1486 The Journal of Thoracic and Cardiovascular SurPatients undergoing an NP palliated with an mBTS showed
a trend toward longer cardiopulmonary bypass, circulatory
arrest, and crossclamp times.
The operative mortality after the NP was 3 of 18 (17%;
95% confidence interval [CI], 4%-41%) for the mBTS,
and 12 of 48 (25%; 95% CI, 13%-37%) for the RV-PA
conduit in the early era (2003-2008). In contrast, the oper-
ative mortality for the recent era (2009-2011) was 2 of 15
(13%; 95% CI, 2%-40%) for the mBTS and 1 of 19
(5%; 95% CI, 0%-26%) for the RV-PA conduit. No signif-
icant difference was seen in the overall operative mortality
or operative mortality between the shunt types during the
early or recent era. In the early era, 14 patients (21%) re-
quired extracorporeal membrane oxygenation after the NP
compared with 1 patient (3%) in the recent era (P ¼ .02).
Of the patients who required extracorporeal membrane ox-
ygenation, 11 (73%) did not survive to hospital discharge
(Figure 1). Two patients required transplantation after the
NP (mBTS, n ¼ 1; RV-PA conduit, n ¼ 1).
The demographics and surgical characteristics at the
BDG procedure are listed in Table 1. In those who under-
went initial palliation with an mBTS, 9 of 21 (43%) under-
went surgical PA patch plasty (bilateral, n ¼ 4; left, n ¼ 2;
right, n ¼ 3) at the BDG procedure. In those palliated with
the RV-PA conduit, 22 of 44 (50%) underwent surgical
patch plasty of the PAs (bilateral, n ¼ 16; left, n ¼ 2; right,
n¼ 4) at the BDG procedure. No difference was seen in the
need for surgical pulmonary arterioplasty between the shunt
types (P ¼ .6). The operative mortality after the BDG pro-
cedure was 2 of 64 (3%) (mBTS, 1/21; RV-PA conduit,
1/44). Three interstage deaths occurred after the BDG pro-
cedure (mBTS, n¼ 1; RV-PA conduit, n¼ 2). Two patients
underwent transplantation after the BDG procedure (both
palliated with an RV-PA conduit). No operative mortality
occurred after the Fontan procedure. Three patients under-
went heart transplantation after the Fontan procedure
(mBTS, n ¼ 1; RV-PA conduit, n ¼ 2).
Overall, 63 patients required at least 1 catheterization be-
tween the NP and BDG procedure (Table 2). Of the 28 pro-
cedures performed in 20 patients palliated with an mBTS,
no interventions were performed. Eight patients did un-
dergo 2 catheterization procedures each. In the RV-PA con-
duit group, 52 procedures were performed in 43 patients.
The indications, location, and interventions performed are
listed in Table 3. Four patients underwent angioplasty
once and two underwent angioplasty at 2 separate
catheterizations.
The cardiac catheterization data are listed in Table 2. A
significantly greater pulmonary/systemic blood flow
(Qp/Qs) ratio was found in those palliated with an mBTS
than in those palliated with an RV-PA conduit (P ¼ .03).
After the BDG procedure, 48 cardiac catheterization pro-
cedures were performed for both groups. In the mBTS
group, 8 patients underwent 10 catheterization proceduresgery c June 2013
TABLE 1. Demographics and operative characteristics for Norwood and bidirectional Glenn procedure for modified Blalock-Taussig shunt and
right ventricle to pulmonary artery conduit
Variable
mBTS RV-PA
P valuePatients (n) Value Patients (n) Value
NP
Patients 33 67
Age at surgery (d) 33 6 .8  3.4 67 7.5  5.1 (4, 10) .38
Male (%) 33 20 (61%) 67 37 (55%) .67
Weight (kg) 33 3.1  0.4 67 3.1  0.5 .64
Gestational age (wk) 33 38.7  1.3 67 38.3  1.5 .10
CPB time (min) 33 188.5  42.5 67 172.7  43.8 .09
Circulatory arrest time (min) 33 19  21.1 66 14.2  22.5 .25
Crossclamp (min) 33 60.4  24.6 66 51  21 .07
SpO2 at discharge 28 78  4 49 79  6 .94
BDG procedure
Patients 21 44
Age (mo) 21 6  2.4 44 5.2  1.7 .17
Weight (kg) 21 6.3  1.4 44 5.7 (5, 7.01) .09
CPB time (min) 20 109.6  57.7 44 97  44.9 .39
Circulatory arrest time (min) 20 13  23.1 44 13.4  25.3 .95
Crossclamp (min) 20 13. 4  14.9 44 4.4  11 .02
Surgical PA intervention 21 9 (43%) 44 22 (50%) .61
mBTS,Modified Blalock-Taussig shunt; RV-PA, right ventricle to pulmonary artery conduit; NP, Norwood procedure; CPB, cardiopulmonary bypass; SpO2, oxygen saturation;
PA, pulmonary artery.
Gist et al Congenital Heart Disease
C
H
Dwith no PA interventions (2 patients underwent 2 catheter-
ization procedures). In the RV-PA conduit group, 25 pa-
tients underwent 38 catheterization procedures (9 patients
underwent 2 catheterizations and 2 patients underwent 3
catheterizations). The indications, location, and inter-
ventions performed are listed in Table 3. Five patientsFIGURE 1. Flow chart demonstrating distribution of patients by procedure and
shunt; RV-PA, right ventricle to pulmonary artery; BDG, bidirectional Glenn (p
The Journal of Thoracic and Carunderwent 2 catheterization procedures, and two underwent
3 catheterization procedures each. Eight patients underwent
angioplasty once, and two each underwent angioplasty at 2
different catheterizations.
The PA echocardiographic dimensions before the NP
and BDG procedure for shunt type are listed in Table 2.type of shunt, including overall mortality.mBTS,Modified Blalock-Taussig
rocedure); NP, Norwood procedure.
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P valuePatients (n) Value Patients (n) Value
Pre-BDG hemodynamics and measurements
Patients 20 38
McGoon ratio 19 1.4  0.6 35 1.5  0.6 .63
Nakata index 20 269.6  223.5 36 264.7  142.3 .93
Qp/Qs at pre-BDG catheterization 20 1.3  0.6 38 0.9  0.3 .03
Interstage 1, catheter PA intervention* 20 0/28 43 8/52 .05
Interstage 2, catheter PA intervention* 8 0/16 25 12/38 .01
Echocardiogram measurements of PA dimension
Patients 19 41
RPA (mm) before NP 19 4.6  0.7 41 4.5  0.7 .94
RPA (mm) before BDG 12 4.1  1.1 32 4.2  1.1 .76
Change in RPA dimension 11 0.5  1.4 29 0.4  1.2 .78
LPA (mm) before NP 19 4.3  0.9 40 4.6  0.7 .26
LPA (mm) before BDG 13 4.3  1.4 31 4.3  1.2 .99
Change in LPA dimension 12 0.3  1.5 27 0.3  1.6 .27
mBTS,Modified Blalock-Taussig shunt;RV-PA, right ventricle to pulmonary artery conduit; BDG, bidirectional Glenn (procedure);Qp, pulmonary blood flow;Qs, systemic blood
flow; PA, pulmonary artery; RPA, right PA; LPA, left PA; NP, Norwood procedure. *Number of patients and ratio represents number of interventions/number of catheterization
procedures.
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DNo significant differences were found in the baseline PA
dimensions or interstage 1 PA growth between shunt
types.
Right ventricular function was assessed at baseline and
before the BDG procedure. No significant difference wasTABLE 3. Indications, type, and location of intervention in patients palliat
left or right of neoaorta






















Right 4 6 Decreased
PA hypop
All patients underwent angioplasty only. PA, Pulmonary artery. *In left RV-PA group, 3 p
interventions; 1 patient underwent 2 PA interventions; in right RV-PA group, 2 patients und
interventions. yIn left RV-PA group, 7 patients underwent 2 catheterization procedures,
patients; in right RV-PA group, 2 patients underwent 2 catheterization procedures; 2 pat
obstruction in 1, and superior vena cava obstruction in 3.
1488 The Journal of Thoracic and Cardiovascular Surfound in ventricular function between those palliated with
an mBTS and an RV-PA conduit at the baseline echocardio-
gram (P ¼ .67) or before the BDG procedure. The median
interval to the follow-up (before BDG) echocardiogramwas
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5 Left in 1
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Bilateral in 2
atients underwent 2 catheterizations and 2 underwent 3 catheterizations, with 3 total
erwent 2 catheterization procedures, with 5 total interventions; 1 patient underwent 2
and 2 underwent 3 catheterization procedures; 7 interventions were performed in 7
ients underwent 2 interventions each. zPersistent chylothorax in 1, neoaortic valve
gery c June 2013
TABLE 4. Demographics and operative characteristics for Norwood
and bidirectional Glenn procedures stratified by right ventricle to











Patients (n) 50 17
Age at surgery (d) 50 8.4  5.5 17 4.8  2.3 <.001
Males (n) 50 24 (48%) 17 13 (77%) .05
Weight (kg) 50 3.1  0.5 17 3.2  0.6 .70
Gestational age
(wk)
50 38.3  1.4 17 38.2  1.8 .83
CPB time (min) 50 176.8  46.3 17 160.6  33.7 .13
Circulatory arrest
time (min)
49 13.9  23.9 17 14.9  18.7 .85
Crossclamp (min) 49 47  21.1 17 62.4  16.3 .004
SpO2 at discharge 33 78  6 16 83  4 .001
BDG procedure
Patients 31 13
Age (mo) 31 5.4  1.9 13 4.6  1.2 .09
Weight (kg) 31 5.8  1.3 13 5.6  0.8 .59
CPB time (min) 31 91.6  45.6 13 109.7  42.3 .22
Circulatory arrest
time (min)
31 5.4  12.3 13 2  7.2 .27
Crossclamp (min) 31 13.7  27.5 13 12.6  20.2 .89
Surgical PA
intervention
31 12 (39%) 13 10 (77%) .05
RV-PA, Right ventricle to pulmonary artery conduit; NP, Norwood procedure;
CPB, cardiopulmonary bypass; SpO2, oxygen saturation; PA, pulmonary artery;
BDG, bidirectional Glenn (procedure).
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gram in the mBTS group was as follows: none in 3, trivial in
7, mild in 5, and moderately severe in 1. Tricuspid valve re-
gurgitation in the RV-PA conduit group was as follows:
none in 1, trivial in 19, mild in 11, mild to moderate in 3,
moderate in 4, and severe in 1. No significant difference
was found in the incidence of tricuspid valve regurgitation
between the 2 groups (P ¼ .39).
Comparison Between Left and Right RV-PAConduit
Position
The patient demographics and operative characteristics
for the comparison of shunt position are listed in Table 3.
The patients in the right RV-PA conduit group were younger
at the NP (P< .001). The oxygen saturation at discharge
from the NP was significantly greater (83%) in the right
RV-PA group than in the left RV-PA group (78%;
P ¼ .001). The difference was not clinically significant.
In the left-sided group (n ¼ 50), 3 different shunt sizes
were used: 4 mm in 7, 5 mm in 40, and 6 mm in 3. In the
right-sided group (n ¼ 17), 2 different shunt sizes were
used: 5 mm in 2 and 6 mm in 15. A significant difference
was present in the shunt size between the left and right
groups (P< .0001). The mean oxygen saturation at the
NP in those palliated with a 5-mm shunt was significantly
lower (78%  6%) than that in those palliated with a
6-mm shunt (82%  4%; P ¼ .01). Despite this difference
in oxygen saturation between shunt sizes, no difference was
found in the number of patients requiring oxygen at dis-
charge (5-mm shunt, 11/31 [35%] vs 6-mm shunt, 5/16
[31%]; P ¼ .52). The right PA dimensions were not differ-
ent in patients palliated with a 5-mm or 6-mm shunt before
the NP or BDG procedure (NP 5 mm, 4.5  0.9 mm vs NP
6 mm, 4.4 0.7 mm, P¼ .26; BDG procedure 5 mm, 4.1
1 mm vs BDG procedure 6 mm, 4.4  0.9 mm; P ¼ .37).
The left PA dimensions were not different in patients
palliated with a 5-mm or 6-mm shunt before the NP or
BDG procedure (NP 5 mm, 4.6  0.8 mm vs NP 6 mm,
4.4  0.7 mm, P ¼ .22; BDG procedure 5 mm, 4.3 
1.4 mm vs BDG procedure 6 mm, 4.5  1 mm, P ¼ .4).
The operative mortality for the left RV-PA conduit posi-
tion was 13 (26%; 95% CI, 14%-38%) and 1 (6%; 95%
CI, 1%-29%) for the right RV-PA conduit position
(P ¼ .09). One patient with the RV-PA conduit to the left
side of the neoaorta died after the BDG procedure. All the
patients who underwent transplantation were those with
the RV-PA conduit to the left side of the neoaorta. None
of those with the RV-PA conduit to the right side of the neo-
aorta were old enough at the last follow-up visit to be con-
sidered for the Fontan procedure.
The patients with the RV-PA conduit to the right side of
the neoaorta required surgical pulmonary arterioplasty at
the BDG procedure more frequently than did the left
RV-PA group (P ¼ .05; Table 3). Twelve patients palliatedThe Journal of Thoracic and Carwith a left RV-PA conduit underwent surgical patch plasty
(bilateral, n ¼ 6; left, n ¼ 2; right, n ¼ 4) compared with
10 patients palliated with a right RV-PA conduit (bilateral,
n ¼ 10) at the BDG procedure (P ¼ .05; Table 4).
The cardiac catheterization and echocardiographic data
stratified by the shunt position are listed in Table 5. The in-
dications, location, and interventions performed for the in-
terstage 1 and interstage 2 period for differences in shunt
position are listed in Table 3.
A simple logistic regression model demonstrated that
a patient with a right RV-PA conduit had a 12.73 times
greater odds of having at least 1 intervention than those
with a left-sided RV-PA conduit (P ¼ .04). A summary of
the PA interventions is presented in Table 5.
The PA dimensions before the NP and BDG procedure
stratified by the shunt position are listed in Table 5. On the
pre-NP echocardiogram, the right and left PAs were signif-
icantly larger in the left RV-PA group (P ¼ .01 and
P ¼ .04 respectively). No differences in the left PA and
right PA dimensions were seen on the follow-up
echocardiogram.
On the baseline echocardiogram, the function in the left
RV-PA group was normal in 14 patients, moderatelydiovascular Surgery c Volume 145, Number 6 1489
TABLE 5. Cardiac catheterization and echocardiographic data stratified by right ventricle to pulmonary artery conduit position
Variable
Left RV-PA conduit Right RV-PA conduit
P valuePatients (n) Value Patients (n) Value
Pre-BDG catheterization hemodynamics and measurements
Patients 25 13
McGoon ratio 24 1.5  0.6 11 1.6  0.5 .43
Nakata index 24 255.7  106.3 12 282.7  200.7 .67
Qp/Qs at pre-BDG catheterization 25 0.9  0.3 13 1  0.3 .27
Interstage 1, catheter PA intervention* 29 3/36 14 5/16 .09
Interstage 2, catheter PA intervention* 21 7/32 4 5/6 .008
Echocardiogram measurements of PA dimension
Patients 27 14
RPA (mm), before NP 27 4.7  0.7 14 4.2  0.5 .01
RPA (mm), before BDG 20 4.1  1 12 4.4  1.4 .62
Change in RPA dimension 17 0.8  0.9 12 0.1  1.5 .09
LPA (mm), before NP 26 4.7  0.7 14 4.3  0.7 .04
LPA (mm), before BDG 19 4.2  1 12 4.5  1.5 .58
Change in LPA dimension 15 0.7  1.4 12 0.2  1.8 .19
RV-PA,Right ventricle to pulmonary artery conduit; BDG, bidirectional Glenn (procedure);Qp, pulmonary blood flow;Qs, systemic blood flow; PA, pulmonary artery; RPA, right
PA; NP, Norwood procedure; LPA, left PA. *Number of patients and ratio represents number of interventions/number of catheterization procedures.
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conduit group, 8 patients had normal function, and 1 had
moderately reduced function. No significant difference
was found in the function between the left and right
RV-PA groups at the baseline echocardiogram (P ¼ 1).
The median interval to the follow-up echocardiogram was
136 days (interquartile range, 113-155 days). On the pre-
BDG echocardiogram, the left RV-PA group demonstrated
normal function in 22 patients, mildly reduced in 2, and
moderately reduced in 1. In the right RV-PA group, right
ventricular function was normal in 10 patients, mildly re-
duced in 2 patients, and moderately reduced in 2 patients.
No significant difference was found in ventricular function
between the right and left RV-PA conduit on the pre-BDG
echocardiogram (P ¼ .38).
Tricuspid valve regurgitation on the follow-up echocar-
diogram in the left RV-PPA group was as follows: none in
1, trivial in 13, mild in 5, mild to moderate in 3, moderate
in 2, and moderate to severe in 2. Tricuspid valve regurgita-
tion in the right RV-PA conduit group was as follows: trivial
in 6, mild in 6, and moderate in 2. No significant difference
was found in tricuspid valve regurgitation between the 2
groups (P ¼ .53).
DISCUSSION
Advances in surgical technique and care for children with
HLHS have improved overall survival. Despite these im-
provements, children with HLHS and variants associated
with a single right ventricle are at high risk of morbidity
and subsequent mortality within the first year of life.16,17
Controversy remains over which shunt to use, and most
retrospective trials have demonstrated equivocal results,
necessitating the need for a prospective trial.4,8,18-20 The1490 The Journal of Thoracic and Cardiovascular SurSingle Ventricle Reconstruction trial reported improved
survival to 12 months in children palliated with an RV-PA
conduit.5 However, children palliated with an RV-PA con-
duit also had an increased need for unplanned cardiovascu-
lar interventions. Most of these interventions were the need
for balloon dilation or stent placement in the shunt or branch
PAs.5 The rate of catheterization interventions (shunt or PA)
for the mBTS group fromNP discharge to stage II discharge
was 26% compared with 41% in the RV-PA conduit group.
That study did not differentiate between shunt and PA inter-
ventions. This compares to 0% for the mBTS group and
15% for the RV-PA group in the present study from the
NP to the BDG procedure. One potential explanation for
the lack of catheter-based PA interventions in patients
with the mBTS between the NP and BDG procedure is
that access to the PAs for intervention is often difficult
and might not be attempted. Although we did not include
shunt interventions in the present study, the largest propor-
tion of catheter-based PA interventions was performed be-
tween the BDG and Fontan procedures (0% in the mBTS
group and 32% in the RV-PA group). This was significantly
greater than that reported by Ohye and colleagues5 in the
Single Ventricle Reconstruction trial and similar to that re-
ported by Mery and colleagues21 (36% reintervention rate).
Bautista-Hernandez and colleagues22 also reported a greater
number of PA interventions in the RV-PA group after the
Fontan procedure. Similar to our findings, they did not
find a difference in the grade of tricuspid valve regurgitation
between shunt types.22 The reasons the mBTS group did not
require catheter-based PA interventions after the BDG
procedure are unclear. The branch PA size decreased in
both shunt types from the baseline echocardiogram to
the follow-up echocardiogram. Consistent with previousgery c June 2013
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tion was increased in the mBTS group.1,2 Mroczek and
colleagues23 recently reported, in a study comparing the he-
modynamics of the mBTS and RV-PA conduit using math-
ematical modeling, that the mBTS resulted in little change
in blood pressure in the PAs with a slightly greater Qp/Qs
ratio and greater right ventricular wall stress. In contrast,
the RV-PA conduit model with the same cardiac output
and systemic and pulmonary vascular resistance demon-
strated pulsatile PA flow, with forward flow into the conduit
occurring for 80% of the cardiac cycle and lower heart
work.23 However, greater shear stress was present at the
proximal and distal portions of the RV-PA conduit, which
could lead to calcification, neointimal proliferation with
subsequent shunt and PA stenosis, and clinical hypox-
emia.23 This might be an explanation for the increased
risk of PA interventions in the RV-PA conduit group. Our
data demonstrated no difference in mortality between chil-
dren palliated with an mBTS or an RV-PA conduit and were
similar to the data reported by another retrospective study.3
The position of the RV-PA conduit to either the right or
left of the neoaortic reconstruction has been reported by in-
vestigators to influence the growth of the PAs, especially the
left PA. Rightward placement of the RV-PA conduit has
been shown to provide a more balanced distribution of pul-
monary blood flow and easier accessibility to the superior
vena cava and right PA at the BDG procedure, theoretically
decreasing the cardiopulmonary bypass time.9,10 The
Qp/Qs ratio was significantly greater if the RV-PA was
placed to the right side of the neoaorta in our population,
suggesting improved pulmonary blood flow. In addition, ox-
ygen saturation by pulse oximetry at NP discharge was sig-
nificantly greater in the right RV-PA conduit group. The
difference in saturation between right- and left-sided place-
ment (83% vs 78%) was likely not clinically significant.
The proportion of interventions after the NP was similar be-
tween the right and left RV-PA group; however, after the
BDG procedure, the risk of PA interventions with the shunt
to the right of the neoaorta was significantly greater than
that with the shunt to the left. This suggests that rightward
placement of the RV-PA conduit could be associated with
either impaired PA growth or technical complications, re-
sulting in acquired PA stenosis. The echocardiographic
measurements of the PAs before any procedure demon-
strated that those who ultimately underwent palliation
with the RV-PA conduit to the right side of the neoaorta
had significantly smaller left and right PAs compared with
those who underwent palliation with the RV-PA conduit to
the left side of the neoaorta. Although the growth of the
PAs was seen in the right RV-PA conduit group at the
follow-up echocardiogram for both the left and right PA,
no growth was seen in the PAs when the RV-PA conduit
was positioned to the left of the neoaorta. One can speculate
then that the need for intervention is not determined by theThe Journal of Thoracic and Carlack of PA growth but rather a lower starting point in the
right RV-PA group that then prompts intervention. Finally,
although our study was designed to differentiate the need
for catheter-based PA interventions with 2 different
RV-PA conduit positions, other factors might play a role
in the growth of the PAs, including the potential for PA com-
pression as it passes behind the newly reconstructed
neoaorta.
Cardiac transplantation had been used as the primary
treatment ofHLHS at our institution before the present study
period. Beginning in 2001, the NP was increasingly used.
During the study period, primary heart transplantation was
performed for HLHS in 30 patients, most of which were per-
formed early in the study period. Currently, staged palliation
is the primary therapy offered at our institution, using the
RV-PA conduit almost exclusively, unless anatomy prohibi-
tive to shunt placement is present. Our operative mortality
for the NP in the early era was high (24%), with a reduction
to 13% that has more recently declined to less than 8%.
Although our study has provided insight into the differ-
ences in PA growth associated with shunt type and position,
we acknowledge data-related limitations. The present study
was a retrospective review at a single institution and was
subject to the limitations associated with retrospective stud-
ies, including missing data. Some differences might be dif-
ficult to detect owing to a lack of power. Differences in PA
growth could have been confounded by the size of the
RV-PA conduit used, with the patients palliated with the
6-mm shunt having greater oxygen saturation at NP dis-
charge and might be reflective of a greater Qp/Qs ratio. De-
spite the lower oxygen saturation at discharge in patients
palliated with a 5-mm shunt, the oxygen requirements
were not different. The limitations resulting from the inher-
ent subjectivity of the portions of echocardiographic data
were minimized by the use of a single echocardiographer
who was unaware of the original clinical reports and history
of PA interventions. Measurement of the PAs off-line might
have resulted in a small amount of measurement error. We
sought to minimize this limitation by having a single cardi-
ologist perform all catheterization measurements. Also, the
procedures performed in during the study period included 4
different surgeons, using different surgical techniques that
might have resulted in a prolongation of operative variables
in the mBTS group and the potential for differential PA
growth in the RV-PA group.
CONCLUSIONS
In the present single-institution review, the use of the
RV-PA conduit or mBTS offers acceptable results and
neither is associated with superior survival. However, the
use of the RV-PA conduit is associated with increased PA
interventions, in particular when the conduit is placed to
the right of the neoaorta. However, there is some suggestion
that overall PA growth is improved, as measured by thediovascular Surgery c Volume 145, Number 6 1491
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Dmore equal distribution of pulmonary blood flow with an
increase in branch PA dimensions. This improved growth
might be confounded by the larger shunt size. Continued
refinements in surgical technique could also obviate any
significant differences and improve overall outcomes.References
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